Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Moderna

Moderna Stock Outlook: Is Wall Street Bullish or Bearish?

Moderna has underperformed the broader market and its peers over the past year, and Wall Street analysts are cautious about the stock’s prospects.

Don't wait for a holiday surge. Now is a good time to get your flu and COVID-19 vaccines

Don't wait for a holiday surge. Now is a good time to get your flu and COVID-19 vaccines

Health officials say it's important to get flu and COVID-19 vaccines ahead of the holidays when respiratory bugs tend to spread

The Independent UK

Option Volatility And Earnings Report For November 4 - 8

Option Volatility And Earnings Report For November 4 - 8

We have some important companies with Palantir, Super Micro computer, Block, Moderna, Qualcomm, Arista Networks, Gilead Sciences and Airbnb all set to report.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Older adults should get 2 doses of the updated COVID shot, CDC says

The 2024-2025 COVID-19 vaccines are available, and the CDC recommends that certain groups get two doses, spaced six months apart.

Norovirus vaccine: How does the trial work, when could it be available and what will it mean for the NHS?

Could the new ‘winter vomiting bug’ vaccine save the NHS in future winters?

The Independent UK

Doctors trial world’s first mRNA vaccine against vomiting bug norovirus

Jab could bring huge health and economic benefits as virus often spreads very rapidly and can be serious

The Guardian - UK

World-first vaccine for vomiting bug norovirus trialled in the UK

The jab uses mRNA technology to tell the immune system to recognise a ‘foreign’ protein on viruses and mount an attack.

The Independent UK

inkl

Read news from The Economist, FT, and more,
with one subscription

World’s first vaccine for winter vomiting bug norovirus to be trialled in UK

World’s first vaccine for winter vomiting bug norovirus to be trialled in UK

Final phase of vaccine trial to start soon using the same technology as Covid-19 jabs

The Independent UK

Earnings Preview: What to Expect From Moderna's Report

Earnings Preview: What to Expect From Moderna's Report

Moderna is all set to release its fiscal third-quarter earnings next month, and analysts project its loss to rise in double digits.

One of science’s greatest achievements: how the rapid development of COVID vaccines prepares us for future pandemics

One of science’s greatest achievements: how the rapid development of COVID vaccines prepares us for future pandemics

Since COVID was first reported in December 2019, there have been more than 775 million recorded infections and more than 7 million deaths from the disease. This makes COVID the seventh-deadliest pandemic in recorded history.

The Conversation

It's time to roll up sleeves for new COVID, flu shots

It's time to roll up sleeves for new COVID, flu shots

Fall means it’s time for just about everybody to get up to date on their flu and COVID-19 vaccines

The Independent UK

Will the XEC COVID subvariant bring a fall wave of infections? What to know about symptoms and spread

Will the XEC COVID subvariant bring a fall wave of infections? What to know about symptoms and spread

The U.S. is coming down from its biggest COVID summer surge yet as a new subvariant emerges—but new vaccines are here, too.

Cancer vaccine breakthrough as tests show positive results on patients with tumours

Cancer vaccine breakthrough as tests show positive results on patients with tumours

The jab, known as mRNA-4359, is developed by Moderna

The Independent UK

Stock Market Today: Stocks Rise in Choppy Day for Markets

Stock Market Today: Stocks Rise in Choppy Day for Markets

Moderna was the worst S&P 500 stock today after the vaccine maker slashed its R&D budget.

Get all your
news in one place.

100's of premium titles.
One news app.

Moderna Stock Plunges as Vaccine Maker Slashes R&D Budget: What to Know

Moderna stock is plunging Thursday after the COVID-19 vaccine maker announced plans to drastically cut its R&D spending to focus on new product approvals.

Is Moderna Stock Underperforming the Nasdaq?

While Moderna has underperformed the broader Nasdaq index in 2024, analysts are reasonably bullish about the stock's potential.

Stocks Finish Higher on Support From Chip Stock Rebound

The S&P 500 Index ($SPX ) (SPY ) Monday closed up +1.16%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +1.20%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +1.30%. Stocks on Monday posted moderate gains on some dip buying following last Friday’s sharp...

The Conversation

New COVID vaccines may be coming to Australia. Here’s what to know about the JN.1 shots

COVID vaccines have unquestionably made a huge difference during this pandemic. For example, it’s estimated COVID shots have saved more than 1.4 million lives in the World Health Organization’s (WHO) European region alone since their introduction in December 2020.

Get all your
news in one place.

100's of premium titles.
One news app.

Stocks Climb on Strength in Chip Stocks

The S&P 500 Index ($SPX ) (SPY ) today is up +0.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.95%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.58%. Stocks today are moderately higher, recovering some of last Friday’s sharp sell-off on some...

Stocks Move Higher on Strength in Chip Stocks and Positive Corporate News

The S&P 500 Index ($SPX ) (SPY ) today is up +0.85%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.64%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.11%. Stocks today are moderately higher, recovering some of last Friday’s sharp sell-off as chip...

International Business Times

Moderna MRNA Mpox Vaccine Shows Promise In Animal Study

An experimental Moderna mRNA vaccine for mpox has demonstrated greater effectiveness than current shots in reducing disease symptoms and duration, according to an animal study published in the journal Cell on Wednesday.

New COVID vaccines are here. What to know about 2024–25 shots as summer surge continues

Citing skyrocketing COVID spread, the FDA announced in late August that it had approved Pfizer’s Comirnaty and Moderna’s Spikevax vaccines early.

The Times of India

When is Canada launching new Covid vaccines targeting KP.2 variant? All you want to know

Close on the heels of US approving vaccines to fight KP.2 variant of Omicron, Health Canada has said they are reviewing updated vaccines that target the strain currently in circulation. The health regulator has said the review process will be completed by early autumn, post which the vaccines will be…

The Independent UK

A new Covid vaccine is available. Here’s why some people might not want it right away

Updated Covid vaccines were approved by the FDA earlier this month

FDA Approves Updated Covid-19 Vaccines From Moderna And Pfizer

FDA approves updated Covid-19 vaccines from Moderna and Pfizer/BioNTech to enhance protection against current variants and combat rising cases.

1 … 6 7 8 9

People

Demetre Daskalakis

Stéphane Bancel

Robert Hopkins Jr

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

US Federal Reserve

World Health Organization

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

385,200 stories

141,190 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play